News
-
Heatwaves worsen sleep apnoea
Wednesday | Oct 29 2025AUSTRALIAN researchers have revealed an increase in the number of people suffering with obstructive sleep apnoea during heatwaves.
-
The ultimate barrier against chafing and sweat rash
Wednesday | Oct 29 2025DERMAL Therapy's Chafing & Sweat Rash Prevention Cream is the ultimate triple-action formula, designed to provide a lubricating barrier, absorb sweat and protect against friction.
-
Mag-Sup powder – a better way to absorb magnesium
Wednesday | Oct 29 2025MAG-SUP powder is a high absorption magnesium supplement for use in magnesium deficiencies.
-
Guild welcomes expanded optometrist prescribing
Tuesday | Oct 28 2025A PROPOSAL by the Optometry Board of Australia to change prescribing rules for optometrists could see them prescribing oral medicines from an approved list to treat potentially sight-threatening eye conditions, bacterial eye infections, eye allergies and short-term eye pain.
-
Could COVID vax fight cancer?
Tuesday | Oct 28 2025PATIENTS with advanced lung or skin cancer who received a COVID mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, according to US research published in Nature.
-
Beware potential rental pitfalls
Tuesday | Oct 28 2025BUYER and tenant advocate Paul Rowe shares some potential pitfalls to watch out for when leasing.
-
Mini-mise pain
Tuesday | Oct 28 2025MEDICHOICE'S new Ibuprofen Mini liquid capsules provide rapid pain relief in an easy-to-swallow format.
-
Want a role in medicine decisions?
Tuesday | Oct 28 2025THE Department of Health, Disability and Ageing is seeking expressions of interest from suitably qualified and experienced individuals - including pharmacists and pharmacologists - who would like to be considered for upcoming member vacancies on national health technology assessment (HTA) committees and sub-committees.
-
Back the bid
Tuesday | Oct 28 2025GLUCOJEL has teamed up with Netball Australia in its bid for the game's inclusion at the Brisbane 2032 Olympics.
-
CKD PBS expansion for Jardiance
Tuesday | Oct 28 2025FROM 01 Nov, Jardiance (empagliflozin 10mg) will be listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of chronic kidney disease (CKD) in adults at moderate-to-severe risk of their condition worsening.
